Rare germline variants in childhood cancer patients suspected of genetic predisposition to cancer. Issue 2 (30th October 2021)

• Record Type: Journal Article
• Authors: Sylvester, Dianne E.; Chen, Yuyan; Grima, Natalie; Saletta, Federica; Padhye, Bhavna; Bennetts, Bruce; Wright, Dale; Krivanek, Michael; Graf, Nicole; Zhou, Li; Catchpoole, Daniel; Kirk, Judy; Latchoumanin, Olivier; Qiao, Liang; Ballinger, Mandy; Thomas, David; Jamieson, Robyn; Dalla‐Pozza, Luciano; Byrne, Jennifer A.
• Is Part Of: Genes, chromosomes & cancer. Volume 61:Issue 2(2022)
• Page Start: 81
• Page End: 93
• Publication Date: 2021-10-30
• Subjects: cancer predisposition -- genomics -- germline variants -- pediatric oncology; Cancer -- Genetic aspects -- Periodicals; 616.994042
• DOI: 10.1002/gcc.23006
• Languages: English
• ISSNs: 1045-2257

Abstract

Abstract: Identification of cancer‐predisposing germline variants in childhood cancer patients is important for therapeutic decisions, disease surveillance and risk assessment for patients, and potentially, also for family members. We investigated the spectrum and prevalence of pathogenic germline variants in selected childhood cancer patients with features suggestive of genetic predisposition to cancer. Germline DNA was subjected to exome sequencing to filter variants in 1048 genes of interest including 176 known cancer predisposition genes (CPGs). An enrichment burden analysis compared rare deleterious germline CPG variants in the patient cohort with those in a healthy aged control population. A subset of predicted deleterious variants in novel candidate CPGs was investigated further by examining matched tumor samples, and the functional impact of AXIN1 variants was analyzed in cultured cells. Twenty‐two pathogenic/likely pathogenic (P/LP) germline variants detected in 13 CPGs were identified in 19 of 76 patients (25.0%). Unclear association with the diagnosed cancer types was observed in 11 of 19 patients carrying P/LP CPG variants. The burden of rare deleterious germline variants in autosomal dominant CPGs was significantly higher in study patients versus healthy aged controls. A novel AXIN1 frameshift variant (Ser321fs) may impact the regulation of β‐catenin levels. Selection of childhood cancer patients for germline testing based on features suggestive of an underlying genetic predisposition could help to identify carriers of clinically relevant germline CPG variants, and streamline the integration of germline genomic testing in the pediatric oncology clinic.